News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
BioMark Announces Update from Ongoing Clinical Trial Using Its Lung Cancer Liquid Biopsy Test as It Prepares for Commercial Launch
January 11, 2023
·
5 min read
BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event January 19, 2023, at 2:00 PM E.T.
January 11, 2023
·
3 min read
Business
PsyBio Announces Appointment of Ian Wisenberg to Board of Directors
January 10, 2023
·
9 min read
Irwin Naturals and Braxia Scientific Sign Letter of Intent Entering Partnership to Launch In-Human Clinical Studies to Support Pharmaceutical Sponsors Across U.S.
January 10, 2023
·
7 min read
mRNA with Defence’s Accum(TM) Program Has Been Initiated
January 10, 2023
·
4 min read
Biotech Beach
Kiora Pharmaceuticals Highlights Anticipated Clinical and Corporate Milestones for 2023; Webcast Now Available on Company Website
January 9, 2023
·
3 min read
Policy
PreveCeutical Signs Intercompany Sol-Gel License Agreement
January 9, 2023
·
5 min read
Izotropic Releases First Video of IzoView
January 9, 2023
·
5 min read
Drug Development
Publication of Data from Adaptimmune’s Completed Phase 1 Trial with Afami-cel in Nature Medicine Demonstrating an Acceptable Safety Profile and Encouraging Responses in Synovial Sarcoma
January 9, 2023
·
5 min read
Drug Development
Marvel Biosciences Completes a Critical Manufacturing Milestone Required to Enter Phase 1 Human Trials Targeting Alzheimer’s Disease and Depression
January 6, 2023
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us